Mochida Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3922800002
JPY
3,400.00
20 (0.59%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
1,05,159.00
1,02,885.00
1,03,261.00
1,10,179.00
1,02,995.00
1,01,801.00
1,09,652.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,05,159.00
1,02,885.00
1,03,261.00
1,10,179.00
1,02,995.00
1,01,801.00
1,09,652.00
Raw Material Cost
51,371.00
50,815.00
48,146.00
50,626.00
48,203.00
49,882.00
55,477.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
3.00
2.00
0.00
0.00
0.00
0.00
1.00
Selling and Distribution Expenses
33,985.00
33,713.00
33,324.00
32,866.00
31,939.00
31,228.00
30,581.00
Other Expenses
1,167.30
1,255.20
1,328.30
1,229.50
1,084.90
1,188.40
1,300.20
Total Expenditure (Excl Depreciation)
97,032.00
97,082.00
94,753.00
95,787.00
90,991.00
92,994.00
99,061.00
Operating Profit (PBDIT) excl Other Income
8127
5803
8508
14392
12004
8807
10591
Other Income
-71.00
682.00
358.00
391.00
12.00
456.00
438.00
Operating Profit (PBDIT)
10,996.00
9,293.00
11,538.00
17,472.00
14,758.00
11,994.00
13,946.00
Interest
3.00
2.00
0.00
0.00
0.00
0.00
1.00
Exceptional Items
0.00
-320.00
177.00
-191.00
-113.00
-2,992.00
613.00
Gross Profit (PBDT)
53,788.00
52,070.00
55,115.00
59,553.00
54,792.00
51,919.00
54,175.00
Depreciation
2,940.00
2,808.00
2,672.00
2,689.00
2,742.00
2,731.00
2,917.00
Profit Before Tax
8,052.00
6,160.00
9,044.00
14,591.00
11,900.00
6,273.00
11,642.00
Tax
2,367.00
1,613.00
2,395.00
4,022.00
3,312.00
1,675.00
3,207.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
5,685.00
4,547.00
6,649.00
10,569.00
8,587.00
4,598.00
8,435.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
5,685.00
4,547.00
6,649.00
10,569.00
8,587.00
4,598.00
8,435.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
5,685.00
4,547.00
6,649.00
10,569.00
8,587.00
4,598.00
8,435.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,30,694.00
1,27,967.00
1,26,775.00
1,28,646.00
1,26,974.00
1,20,665.00
1,25,110.00
Earnings per share (EPS)
160.36
126.79
178.93
277.39
222.27
117.55
212.86
Diluted Earnings per share
160.36
126.79
178.93
277.39
222.27
117.55
212.86
Operating Profit Margin (Excl OI)
7.73%
5.64%
8.24%
13.06%
11.65%
8.65%
9.66%
Gross Profit Margin
10.45%
8.72%
11.35%
15.68%
14.22%
8.84%
13.28%
PAT Margin
5.41%
4.42%
6.44%
9.59%
8.34%
4.52%
7.69%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 2.21% vs -0.36% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 25.03% vs -31.61% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 28.52% vs -22.98% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 50.00% vs 0.00% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Mochida Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
1,05,159.00
2,59,594.00
-1,54,435.00
-59.49%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,05,159.00
2,59,594.00
-1,54,435.00
-59.49%
Raw Material Cost
51,371.00
1,64,865.00
-1,13,494.00
-68.84%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
3.00
1,627.00
-1,624.00
-99.82%
Selling and Distribution Expenses
33,985.00
55,274.00
-21,289.00
-38.52%
Other Expenses
1,167.30
1,458.50
-291.20
-19.97%
Total Expenditure (Excl Depreciation)
97,032.00
2,36,351.00
-1,39,319.00
-58.95%
Operating Profit (PBDIT) excl Other Income
8,127.00
23,243.00
-15,116.00
-65.03%
Other Income
-71.00
3,504.00
-3,575.00
-102.03%
Operating Profit (PBDIT)
10,996.00
46,846.00
-35,850.00
-76.53%
Interest
3.00
1,627.00
-1,624.00
-99.82%
Exceptional Items
0.00
1,209.00
-1,209.00
-100.00%
Gross Profit (PBDT)
53,788.00
94,729.00
-40,941.00
-43.22%
Depreciation
2,940.00
20,099.00
-17,159.00
-85.37%
Profit Before Tax
8,052.00
26,330.00
-18,278.00
-69.42%
Tax
2,367.00
7,343.00
-4,976.00
-67.77%
Provisions and contingencies
0
0
0.00
Profit After Tax
5,685.00
18,986.00
-13,301.00
-70.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
5,685.00
18,986.00
-13,301.00
-70.06%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
5,685.00
18,986.00
-13,301.00
-70.06%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,30,694.00
1,71,625.00
-40,931.00
-23.85%
Earnings per share (EPS)
160.36
385.70
-225.34
-58.42%
Diluted Earnings per share
160.36
385.70
-225.34
-58.42%
Operating Profit Margin (Excl OI)
7.73%
8.95%
0.00
-1.22%
Gross Profit Margin
10.45%
17.89%
0.00
-7.44%
PAT Margin
5.41%
7.31%
0.00
-1.90%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 10,515.90 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 2.21% vs -0.36% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 568.50 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 25.03% vs -31.61% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,106.70 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 28.52% vs -22.98% in Mar 2024

Annual - Interest
Interest 0.30 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 50.00% vs 0.00% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.73%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024